Nurse-Led Micro-Elimination of Hepatitis C in Supported Housing Sites for Networks of PWID in Canada

By Ana Balkandjieva

19 July 2022

People who inject drugs

Achieving the World Health Organization’s goal of eliminating hepatitis C (HCV) by 2030 requires enhanced HCV testing and treatment among people who inject drugs (PWID). Micro-elimination of HCV is a strategy to target HCV testing and treatment efforts to specific segments of the population.

A study, published in Public Health Nursing, described a nurse-led micro-elimination approach of hepatitis C in supported housing sites for networks of PWID in Victoria, Canada.

The study abstract can be accessed here.

Related materials

The Time Bomb Is Ticking... Defuse Hepatitis C, the Viral Time Bomb!

Press Release — 25 July 2013

On World Hepatitis Day, millions of people with HCV and their advocates have issued a petition calling on Dr. Margaret Chan to act urgently to increase global access to HCV tools. More

30 July 2013News Press Releases

Today New Hepatitis Resolution is Passed at World Health Assembly; Challenges WHO and Member States to Act

Press Release – 22 May 2014 – Geneva

The World Health Assembly passed new Hepatitis Resolution committing WHO and UN member states to urgent action to address the global hepatitis pandemic. More

10 June 2014News Press Releases

Nobody Left Behind

The importance of integrating people who inject drugs into HCV treatment programs. Arguments from a public health and human rights perspective.

"We estimate that around 2 million people who inject drugs globally need treatment immediately." More

26 June 2014Advocate Advocacy Tools

Know Your Risk!

Hepatitis C & injection drug use

A booklet, developed by Alliance for Public Health and Médecins du Monde, provides to people who inject drugs important information about hepatitis C More

3 January 2017Learn Prevention

Trainings

Hepatitis C and harm reduction for people who use drugs

In 2016, Médecins du Monde organized a series of trainings on hepatitis C intended for its Harm Reduction international teams and partners with a focus on people who use drugs. More

12 January 2017Advocate Advocacy Tools

Hepatitis C among People Who Use Drugs

61st CND side event (March 2018)

A side event, organized during the 61st CND, aimed at raising the profile of viral hepatitis as a major health issue and promoting harm reduction and drug policy reform. More

9 April 2018News Partner News

Global Declaration to Eliminate Hepatitis C in People Who Use Drugs: A Call for Political Leaders to Take Action

Sign the pledge! If elimination by 2030 is to be achieved, the global community needs to act immediately. More

31 October 2018Advocate Policy Statements

African Declaration to Eliminate Hepatitis C and Improve the Health of People Who Use Drugs

Cape Town, South Africa, 20 February 2020

People working to eliminate hepatitis C in the African region express alarm regarding the increasing impact of drug use, hepatitis C, and other viral co-infections on the well-being of PWUD. More

21 February 2020Advocate Policy Statements

Hepatitis C Testing and Treatment in Community Pharmacies in Scotland

Pharmacy-based HCV testing as an effective way to PWUD community testing, increasing linkage to care for affected populations in rural or remote areas. More

3 February 2022Learn Care

Hepatitis C Reinfection Post Scale-Up of Direct-Acting Antivirals Among PWID

HCV reinfection rates increased following scale-up of DAAs among PWID in Scotland. Prompt diagnosis of reinfection needs to be integral to national strategies for PWID. More

28 February 2022Learn Treatment